Paolo Pucci

CIK 1436861 · Chief Executive Officer · last filed 2026-05-06

"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.

Loading insider history…
Disclosed Exposure

$0

Companies

5

Total Filings

80

Lifetime Open-Market Net

-$206.3K

Holdings By Company

Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
Symbol Role Shares Price Disclosed Exposure Lifetime OM Net Filings Latest Filed
WSTw Director 11,854 $0 12 2026-05-06
REPL Director $8.88 $0 7 2026-04-07
Merus N.V. (MRUS) Delisted Director $90.00 $0 7 2025-12-12
LUMOS PHARMA, INC. (NLNK) Delisted Director $0 3 2018-05-25
DYAX CORP (DYAX) Delisted Director 0 -$206.3K 6 2016-01-22

Recent Filings · Page 8 of 8

80 filings
Form 4 transactions across all companies, newest first.
Filed Symbol Action Net Shares Net $ Link
2010-07-20 Grant (A) $0
2010-01-22 Mixed −6,405 -$22.6K
2009-11-13 Buy (P) +5,000 $17.4K
2009-06-10 Tax (F) −19,875 -$108.7K
2009-05-15 Buy (P) +2,500 $9.6K
2009-02-25 Tax (F) −23,750 -$93.8K
2009-02-06 Grant (A) +67,500 $0
2008-11-17 Buy (P) +18,250 $48.8K
2008-08-21 Grant (A) +37,706 $136.5K
2008-06-11 Grant (A) +125,000 $0
Showing 7180 of 80
Page 8 of 8
Codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.